We are live on ! Find out more
GAMA

Graticule Asia Macro Advisors Portfolio holdings

AUM $649M
This Fund
S&P 500
This Quarter Est. Return
+9.62%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$829M
AUM Growth
-$583M
Cap. Flow
-$490M
Cap. Flow %
-59.1%
Top 10 Hldgs %
45.9%
Holding
155
New
59
Increased
13
Reduced
16
Closed
57

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$45.8M
2
KLAC icon
KLA
KLAC
+$32.6M
3
OVV icon
Ovintiv
OVV
+$32.3M
4
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$25.3M
5
AMZN icon
Amazon
AMZN
+$21.1M

Sector Composition

Rank Sector Weight
1 Communication Services 9.72%
2 Financials 7.83%
3 Industrials 5.96%
4 Healthcare 5.37%
5 Energy 4.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASTE icon
76
Astec Industries
ASTE
$1.16B
$1.45M 0.18%
21,500
+4,021
+23% +$251K
JWN
77
DELISTED
Nordstrom
JWN
$1.4M 0.17%
+29,130
New +$1.58M
XBI icon
78
State Street SPDR S&P Biotech ETF
XBI
$9.95B
$1.36M 0.16%
+23,010
New +$1.42M
AVXS
79
DELISTED
AveXis, Inc. Common Stock
AVXS
$1.28M 0.15%
26,895
-2,230
-8% -$119K
MLM icon
80
Martin Marietta Materials
MLM
$31.5B
$1.22M 0.15%
5,500
-2,550
-32% -$524K
PBYI icon
81
CALL
Puma Biotechnology
PBYI
$404M
$1.21M 0.15%
39,500
VMC icon
82
Vulcan Materials
VMC
$34.8B
$1.19M 0.14%
9,500
-2,500
-21% -$302K
AERI
83
DELISTED
Aerie Pharmaceuticals
AERI
$1.04M 0.13%
27,400
+11,400
+71% +$431K
WBA
84
DELISTED
Walgreens Boots Alliance
WBA
$993K 0.12%
+12,000
New +$992K
AKAO
85
DELISTED
Achaogen Inc
AKAO
$977K 0.12%
+75,000
New +$514K
RGNX icon
86
Regenxbio
RGNX
$620M
$912K 0.11%
49,150
-18,350
-27% -$351K
MDCO
87
DELISTED
Medicines Co
MDCO
$886K 0.11%
+26,100
New +$926K
PBYI icon
88
Puma Biotechnology
PBYI
$404M
$768K 0.09%
25,000
+3,138
+14% +$136K
HALO icon
89
CALL
Halozyme
HALO
$9.79B
$761K 0.09%
+77,000
New +$843K
PTGX icon
90
Protagonist Therapeutics
PTGX
$8.79B
$700K 0.08%
31,827
AGIO icon
91
CALL
Agios Pharmaceuticals
AGIO
$1.79B
$522K 0.06%
+12,500
New +$656K
BLUE
92
DELISTED
bluebird bio
BLUE
$444K 0.05%
+556
New +$442K
ACAD icon
93
Acadia Pharmaceuticals
ACAD
$4.43B
$404K 0.05%
+14,000
New +$370K
EXEL icon
94
Exelixis
EXEL
$13.3B
$398K 0.05%
26,700
-157,500
-86% -$2.27M
JUNO
95
DELISTED
Juno Therapeutics, Inc.
JUNO
$382K 0.05%
20,250
-11,250
-36% -$275K
SRPT icon
96
Sarepta Therapeutics
SRPT
$1.57B
$284K 0.03%
10,350
-30,550
-75% -$1.23M
NSTG
97
DELISTED
NanoString Technologies, Inc.
NSTG
$268K 0.03%
12,000
RCKT icon
98
Rocket Pharmaceuticals
RCKT
$340M
$99K 0.01%
4,054
-12,575
-76% -$359K
AAPL icon
99
CALL
Apple
AAPL
$4.54T
-3,760,000
Closed -$106M
AAPL icon
100
Apple
AAPL
$4.54T
-481,200
Closed -$13.6M

Similar funds

Graticule Asia Macro Advisors's Q4 2016 Portfolio in Review

As of Q4 2016, Graticule Asia Macro Advisors held 155 positions worth $829M, down 41% from $1.41B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Graticule Asia Macro Advisors withdrew a net $490M in Q4 2016, closing 57 positions and reducing 16 holdings. Its most notable exit was Visa, an estimated $45.8M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 9.7% of assets, up from 0.68% a quarter earlier, followed by Financials and Industrials.

Against the trend, Graticule Asia Macro Advisors opened a new position in Microsoft worth $33.3M.

  • Graticule Asia Macro Advisors's largest Q4 2016 buy was Microsoft: 535,790 shares worth $33.3M.
  • Graticule Asia Macro Advisors added most to Charter Communications in Q4 2016, an estimated $6.18M increase.
  • Graticule Asia Macro Advisors's biggest Q4 2016 reduction was Williams Companies, cutting an estimated $11.3M.
  • Graticule Asia Macro Advisors fully exited Visa in Q4 2016, selling an estimated $45.8M.
  • Graticule Asia Macro Advisors's ten largest holdings make up 46% of its $829M portfolio in Q4 2016.
  • Graticule Asia Macro Advisors opened 59 new positions and closed 57 in Q4 2016.
  • Graticule Asia Macro Advisors's portfolio value fell 41% quarter-over-quarter to $829M.

Based on Graticule Asia Macro Advisors's 13F filing for Q4 2016, filed 14 Feb 2017.